Selected publications
-
Conflicting interpretation of genetic variants and cancer risk by commercial laboratories as assessed by the prospective registry of multiplex testing.
Journal of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 64 -
A recurrent ERCC3 truncating mutation confers moderate risk for breast cancer.
Cancer Discovery.
2016
Academic Article
GET IT
Times cited: 14